Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
6(29%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
2
10%
Ph not_applicable
8
38%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

6

trials recruiting

Total Trials

21

all time

Status Distribution
Active(7)
Completed(7)
Terminated(1)
Other(6)

Detailed Status

Completed7
Recruiting5
unknown5
Not yet recruiting1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
6
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (20.0%)
N/A8 (80.0%)

Trials by Status

recruiting524%
not_yet_recruiting15%
suspended15%
terminated15%
completed733%
unknown524%
active_not_recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT04649892Phase 2

Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder

Recruiting
NCT07721155

Objective Neurocognitive Assessment of Young Children With Sickle Cell Disease by Eye-Tracking

Completed
NCT06058897Not Applicable

Magnetic Resonance Imaging (MRI) and Eye-tracking Predictive Markers of Cognitive Ageing.

Active Not Recruiting
NCT05186077

Brain Circuitry Analysis in Bipolar Disorder

Terminated
NCT04442061Phase 2

Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus

Completed
NCT05061953

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

Recruiting
NCT06283524

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

Completed
NCT06256731

ETNA-MS Device Validation Study

Completed
NCT05661266

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Completed
NCT02165410Not Applicable

MRI Study of Cerebral Blood Flow in Development Disorders in Children

Completed
NCT07377227Not Applicable

Social COgnition Screening

Not Yet Recruiting
NCT06334588Not Applicable

Understanding the Mechanisms of Autism : an MRI and Social Cognition Study

Recruiting
NCT06891612Not Applicable

Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects

Completed
NCT07110493Not Applicable

Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements

Recruiting
NCT05212727

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Suspended
NCT05176704

Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease

Recruiting
NCT05277740

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Unknown
NCT05186948

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

Unknown
NCT03711045

An Eye Tracking Study of Affective Disorder Patients With Suicide Risk

Unknown
NCT03474796Not Applicable

Clinical Observation During Anaesthetic Induction: Which Difference Between Novice and Expert ?

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
21